Here we clearly demonstrated that the VRP-FLT3 vaccination overcame the intrinsic self-tolerance mechanisms to induce a strong antibody response to FLT3 in the tumor-bearing mice in both of our leukemia and lymphoma models. The gene discussed is FLT3; the disease is leukemia.